Elizabeth Holmes trial: jury finds Theranos founder guilty on four fraud counts

Elizabeth Holmes, founder of Theranos, has been found guilty on four of 11 charges of fraud, concluding a high-profile trial that captivated Silicon Valley and chronicled the missteps of the now-defunct blood testing startup.

On Monday, the seventh day of deliberations, the jury told US district judge Edward Davila that it was unable to reach a unanimous verdict on those three charges. In response, Davila encouraged them to deliberate further, but jurors later returned and rendered their final decision.

As the verdict was read, the Theranos founder bowed her head, remained seated and expressed no visible emotion. Her partner, Billy Evans, showed agitation in earlier moments but appeared calm during the verdict reading.

Holmes was found guilty on four charges: one count of conspiracy to defraud investors, and three counts of wire fraud against investors.

Holmes was meanwhile acquitted on three charges, including one conspiracy to defraud patients and two charges related to patients who received inaccurate test results. One charge was thrown out earlier in the trial, and the jury did not come to a verdict on the remaining three charges.

Holmes, 37, faces prison time, although a sentencing date has not been set. She pleaded not guilty and is expected to appeal.

After the judge left the courtroom to meet with jurors individually, Holmes got up to hug her partner Billy Evans and her parents before leaving with her lawyers.

Over the course of nearly four months, federal prosecutors called 29 witnesses, outlining missteps and alleged fraud Holmes committed during her 15-year reign as CEO.

Holmes founded the company after dropping out of Stanford at 19 years old, promising a revolutionary technology that could run hundreds of health tests on just a drop of blood. But the company ultimately fell short of its ambitious pledge.

Once a charismatic figure, Holmes was initially hailed as a visionary. As Theranos grew, the company attracted big-name investors including the former secretaries of state George Shultz and Henry Kissinger. At its height, Theranos was valued at more than $9bn.

But cracks in the glossy surface began to show in 2015 when Wall Street Journal reporting revealed that its in-house tests had massive inaccuracies, and that the company was performing other tests using traditional blood drawing methodology and outside labs.

The fall of Theranos has been followed with perhaps even more fervor than its spectacular rise, inspiring multiple documentaries, a feature film, and an upcoming television show. Starting in late August, throngs of reporters have lined up in the early morning hours for a seat inside the federal court house in San Jose, California.

Those arguments came to a head when Holmes made the stunning decision to take the stand in her own defense, arguing she made decisions in good faith and did not knowingly commit fraud.

Prosecutors repeatedly pointed to documents that Holmes admitted to doctoring before sharing with potential partners, adding the logos of pharmaceutical firms and falsely implying they had endorsed the methodology.

Her attorneys also put forward a line of defense that Holmes was abused by her former romantic and business partner Sunny Balwani, who served for ten years as co-president of the company.

Balwani has strongly denied claims of mistreating Holmes. He faces his own trial in 2022 for fraud.

Holmes did not respond to questions lobbed at her during a walk from the courthouse to the nearby hotel on Monday where she has stayed during jury deliberations.

Holmes will remain free on bond while awaiting sentencing, which will be determined by the judge.

The Associated Press contributed reporting